Skip to main content

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Surveillance AFter Extremity Tumor surgerY

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Surveillance AFter Extremity Tumor surgerY

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCEĀ®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCEĀ®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF

Adaptive COVID-19 Treatment Trial (ACTT)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Adaptive COVID-19 Treatment Trial (ACTT)

A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • …
  • Next page Next
  • Last page Last
Subscribe to